Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Chemotherapy-induced Neutropenia × balugrastim × Clear all

Phase

Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Chemotherapy-induced Neutropenia 1

Interventions

pegfilgrastim 3 NPI 2358 2 Granulocyte Colony-Stimulating Factor 2 Doxorubicin 2 Docetaxel 2 balugrastim 1 Drug Therapy 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01126190 2023-03-28

NEUGR-003

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 3 Completed

381 enrolled 13 charts

Chemotherapy-induced Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡